NEW YORK (TheStreet) -- CHANGE IN RATINGS
Astoria Financial (AF) upgraded at Barclays to Overweight from Equal Weight based on improving fundamentals and valuation. 2009 and 2010 EPS estimates set at $0.42 and $0.94, respectively. Price target upped to $14 from $12.
American Capital Agency
Bed Bath & Beyond Leaps on Bank of America Upgrade, Fading 'Meme' Interest
BofA analyst Curtis Nagle says Bed Bath & Beyond shares are trading closer to their pre 'meme mania' levels, and represent good retail sector value.
downgraded at Merrill/BofA to Neutral from Buy as robust earnings are already priced into shares. Price target cut to $23 from $25. 2009 and 2010 EPS estimates set at $4.73 and $4.98.
upgraded at Barclays to Overweight from Equal Weight on expectations of robust 3Q. 2009 and 2010 EPS raised to $1.06 from $0.96 and to $1.65 from $1.36, respectively. Price target lifted to $35 from $30.
upgraded at Collins Stewart from Hold to Buy. $60 price target. E&P portfolio will begin to require less capital in the future.
upgraded at from Underperform to Market Perform at Friedman, Billings Ramsey. $37 price target. Deposit base is attractive, but the company has late-cycle credit exposure.
Dr. Pepper Snapple
rated new Buy at Citigroup. $35 price target. Stock was also added to the Top Picks Live list, as the company has been steadily gaining market share.
upgraded at Barclays to Equal Weight from Underperform. 2009 EPS estimate maintained at $1.60, 2010 raised to $2.85 from $2.70. Shares now seen reaching $60, up from $40.
initiated at Barclays with an Overweight rating and $16 price target. Bank deals should drive significant EPS growth through 2011. 2009 and 2010 EPS estimates set at $0.48 and $0.85, respectively.
upgraded at FBR from Market Perform to Outperform. $5 price target. Company has enough capital to eventually return to profitability.
downgraded at Merrill/BofA to Neutral from Buy. 2009 and 2010 EPS estimates set at $4.75 and $4.78, respectively. $28 price target.
upgraded at JMP from Underperform to Market Perform. Estimates also raised, to reflect better fixed-income results.
rated new Buy at Citigroup. $61 price target. Company has returned to become the true leader in the industry and will benefit in the near term from a weaker dollar.
upgraded at Barclays to Overweight from Equal Weight. 2009 and 2010 EPS estimates set at -$0.76 and -$0.45, respectively. Price target boosted to $35 from $22.
New York Community Bancorp
( NYB) upgraded at FBR from Underperform to Market Perform. $10 price target. Company will have higher earnings volatility than its peers, but also trades at an attractive valuation.
initiated at Barclays with an Overweight rating and $15 price target. 2009 and 2010 EPS estimates set at $0.84 and $1.29, respectively.
upgraded at Thomas Weisel to Overweight from Market Weight on rebounding metrics, a compelling valuation, and raising industry multiples. 2010 and 2011 EPS estimates set at $0.73 and $0.88, respectively. Price target boosted to $18 from $12.
upgraded at FBR from Underperform to Market Perform. $43 price target. Valuation call, though the stock offers high-risk, high-reward potential.
downgraded at Goldman from Buy to Neutral. Valuation call and 2010 guidance may be difficult to achieve.
upgraded at Merrill/BofA to Buy from Neutral on improving traffic trends. Price target set at $54.
Polo Ralph Lauren
upgraded at Goldman to Buy. $90 price target. Estimates also boosted, to reflect expanding margins and expected share buybacks.
upgraded at Barclays to Overweight from Equal Weight as company has ability to expand market share. Maintain 2009 and 2010 EPS estimates at $1.55 and $1.70, respectively. Price target surged to $55 from $38
upgraded at Goldman from Neutral to Conviction Buy. Company is the least hedged power producer.
downgraded at FBR from Market Perform to Underperform. $2.50 price target. Company has relatively high risk, but low potential returns, relative to its peers.
rated new Outperform at Oppenheimer. $250 price target. Company should continue to grow faster than the market.
Thomas & Betts
( TNB) upgraded at Barclays to Overweight from Equal Weight on valuation. 2009 and 2010 EPS estimates maintained at $2.00 and $2.20, respectively. Price target elevated to $43 from $24.
upgraded at FBR from Underperform to Market Perform. $21 price target. Company is high-quality, but still has limited overall upside potential.
initiated at Merrill/BofA with a Buy rating and $50 price target. Global Calvin Klein expansion driving upside.
upgraded from Market Perform to Outperform at Friedman, Billings Ramsey. $20 price target. Company should return to profitability by 2011 and has relatively low risk.
STOCK COMMENTS / EPS CHANGES
( CBE) price target, estimate raised at Barclays. Price target to $47 from $36. 2009 EPS estimate maintained at $2.35, 2010 lifted to $2.50 from $2.45. Reiterate Overweight rating.
price target up at Thomas Weisel to $33 from $29. Maintain Market Weight rating. 2009 and 2010 EPS estimates set at $1.56 and $1.55, respectively.
estimates, target cut at UBS. Estimates were lowered through 2011. Competition will temper gross margin gains. Neutral rating and new $26.50 price target.
cut from Conviction Buy List at Goldman. Stock has outperformed its peers over the past couple of months.
target raised at Kaufman to $54. XRX is not a threat to the company and HPQ could even possibly gain more market share in the near term. Buy rating.
numbers boosted at FBR to $22. Estimates also increased, as the company's near-term sales are likely tracking at or above expectations. Outperform rating.
Oil States International
price target increased at Barclays to $40 from $30 to reflect sustainable earnings power of OIS's Oil Sands. 2009 and 2010 EPS estimates elevated to $2.40 from $2.27 and to $1.90 from $1.75, respectively. Maintain Outperform rating.
price target lifted at Credit Suisse to $55 from $51. Comfortable with PRU's liquidity and debt profile. 2009 and 2010 EPS estimates set at $5.77 and $5.80, respectively. Maintain Outperform rating.
numbers boosted at Morgan Stanley to $26. Estimates also raised, to reflect an improving spending environment. Overweight rating.
price target raised at Thomas Weisel to $24 from $19 on optimism for topline and margin recovery. 2009 and 2010 EPS estimates set at $0.82 and $0.96, respectively. Reiterate Market Weight rating.
( VLCM) price target raised at Thomas Weisel to $15 from $11. Reiterate Market Weight rating.
This article was written by a staff member of TheStreet.com.